Ralph Wäsch

31PUBLICATIONS
109CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyPhysiotherapyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Jun 02, 2026
Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors.

|Apr 03, 2026
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Kristina Maas-Bauer, Thomas Meyer, Mehtap Yücel

|Feb 27, 2026
Inpatient Rehabilitation Improves Physical and Mental Health in Multiple Myeloma: A Prospective Cohort Study.

Jan Räder, Andriani Vasakou, Gabriele Ihorst

|Sep 22, 2025
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.

Ajai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria

|Jun 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.

Maximilian Merz, Nico Gagelmann, Samih Smaili

Pageof 6

Frequent Collaborators

12 joint publications

Gabriele Ihorst

12 joint publications

Robert Zeiser

8 joint publications

Jesús Duque-Afonso

8 joint publications

Jürgen Finke